首页> 外国专利> IMPROVED SOLID-PHASE PEPTIDE SYNTHESIS AND AGENT FOR USE IN SUCH SYNTHESIS

IMPROVED SOLID-PHASE PEPTIDE SYNTHESIS AND AGENT FOR USE IN SUCH SYNTHESIS

机译:改进的固相肽合成及用于此类合成的试剂

摘要

Peptides X-AA1-AA2...AA n-Y, wherein AA is an L- or D-amino acid residue, X ishydrogen or an amino protective group, Y is OH,NH2 or an amino acid sequence comprising from 3 to 9 amino acid residues and nis an integer greater than 2, are prepared by solid phasesynthesis, preferably using Fmoc-chemistry, the improvement consisting in thatthe C-terminal part attached to the solid phase comprises apre-sequence comprising from 3 to 9, preferably from 5 to 7, amino acidresidues independently selected from native L-amino acids havinga side chain functionality which is suitably protected during the couplingsteps and having a propensity factor P.alpha. 0.57 and a propensityfactor P.beta. 1.10, preferably Lys and/or Glu, or the corresponding D-aminoacids and said pre-sequence is optionally cleaved from theformed peptide.
机译:肽X-AA1-AA2 ... AA n-Y,其中AA是L-或D-氨基酸残基,X是氢或氨基保护基,Y为OH,NH2或包含3至9个氨基酸残基和n是大于2的整数,由固相制备合成,最好使用Fmoc-化学方法,其改进之处在于连接到固相的C末端部分包括包含3至9个氨基酸,优选5至7个氨基酸的预序列独立地选自具有以下特征的天然L-氨基酸的残基:在连接过程中受到适当保护的侧链功能步骤并具有倾向因子P.alpha。 > 0.57和倾向P因子> 1.10,最好是Lys和/或Glu,或相应的D-氨基酸和所述预序列可任选地从形成的肽。

著录项

  • 公开/公告号CA2265900C

    专利类型

  • 公开/公告日2007-07-31

    原文格式PDF

  • 申请/专利权人 ZEALAND PHARMACEUTICALS A/S;

    申请/专利号CA19972265900

  • 发明设计人 LARSEN BJARNE DUE;HOLM ARNE;

    申请日1997-09-09

  • 分类号C07K1/04;

  • 国家 CA

  • 入库时间 2022-08-21 20:54:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号